NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +66.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |